Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,161 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04262492Recruiting
Registry of adults with APS on blood thinners
This study keeps an international registry of people with antiphospholipid syndrome (APS) who are taking direct oral blood thinners. It may help doctors better understand how APS patients do over time and improve future care, even if you’re not asked to change treatment.
NancyAges Any age - NCT04321512Recruiting
Blood test study for people with heart or stroke problems
This study looks at a type of white blood cell (monocytes) in blood to understand differences in people with certain heart attacks, stable heart disease, or ischemic stroke. It may help researchers learn why these conditions happen and how the immune system may be involved.
Farmington, ConnecticutAges 18 years+ - NCT04344769Recruiting
Studying how a kidney-protecting pathway works in ADPKD
This study looks at how the body’s “Nrf2 response” works in people with autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand disease biology and future treatments by comparing kidney-related signals in ADPKD patients and healthy volunteers.
Rochester, MinnesotaAges 18–30 - NCT04265703Recruiting
Ultrasound-guided line placement for hard-to-access veins
This study tests a specific ultrasound-guided technique to place a central venous catheter (a medical access line) when jugular veins are difficult to access. It may help reduce failed attempts and improve safety in people who need this kind of line for medical care.
GuadalajaraAges 18–80 - NCT04333537RecruitingPhase 2/Phase 3
Sentinel node biopsy versus standard neck surgery for early mouth cancer
This trial compares two ways of checking whether early oral cavity squamous cell cancer has spread to neck lymph nodes. It tests whether sentinel lymph node biopsy can find spread as well as standard neck dissection, while potentially reducing more extensive surgery for some people.
Birmingham, AlabamaAges 18 years+ - NCT04293042RecruitingEarly Phase 1
BK virus treatment using donor immune cells after transplant
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
Philadelphia, PennsylvaniaAges 1 month–25 years - NCT04263038RecruitingPhase 4
Watchful waiting versus blood thinners for small lung clots
This trial compares close monitoring (“watch and wait”) versus taking the blood thinner rivaroxaban in people with a small type of lung blood clot. It aims to find out whether low-risk patients can safely avoid or reduce anticoagulation while still staying healthy.
Woluwe-Saint-Lambert, Brussels CapitalAges 18 years+ - NCT04370574Recruiting
Testing blood or tissue markers for suspected pancreatic cancer
This trial looks for “soluble biomarkers” (markers that can be found in body fluids like blood) for people who have a pancreatic mass and may have pancreatic ductal adenocarcinoma. The goal is to improve how pancreatic cancer is identified, especially using information taken from an endoscopic ultrasound biopsy.
Montpellier, MontpellierAges 18 years+ - NCT04332367RecruitingPhase 2
New chemo plus ramucirumab for lung cancer after maintenance
This Phase 2 trial studies a combination of chemotherapy (carboplatin and a “taxane”) plus ramucirumab for people with advanced lung cancer that came back or progressed after prior maintenance treatment. It may help by attacking cancer growth after earlier therapy no longer worked.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04329065RecruitingPhase 2
Vaccine with targeted breast cancer drugs before surgery
This Phase 2 trial tests whether adding a cancer vaccine (with GM-CSF) to standard HER2-targeted chemotherapy before surgery improves treatment outcomes for HER2-positive breast cancer. If you join, you’ll receive planned medicine before surgery to treat the tumor, then continue with the study schedule.
Seattle, WashingtonAges 18 years+ - NCT04354077Recruiting
Deep brain stimulation for opioid addiction
This study tests whether deep brain stimulation (DBS), a surgical treatment that uses electrical pulses to target specific brain areas, can help reduce cravings and relapse in people with opioid use disorder who haven't found relief from other treatments.
Pittsburgh, PennsylvaniaAges 22–65 - NCT04296071Recruiting
Testing blood markers after heart surgery in infants
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
Boston, MassachusettsAges Up to 1 year - NCT04328298Recruiting
Register study of people in France eligible for CAR-T therapy
This study collects health data from people in France who received CAR-T treatment or are eligible to receive it. It helps doctors and researchers understand who can get CAR-T and how treatment is used in real life.
AmiensAges birth–99 years - NCT04373720Recruiting
MRI scan to tell scar from tumor in treated brain glioma
This study uses an advanced MRI scan to help doctors tell the difference between radiation scar (radiation necrosis) and returning glioma (recurrent glioma) after prior treatment. It may help guide the next steps for care if you have a new or changing brain lesion.
Houston, TexasAges 18 years+ - NCT04339218RecruitingPhase 3
Cryoablation plus pembrolizumab and chemotherapy for lung cancer spread
This trial studies whether freezing a small number of lung cancer spots (cryoablation) alongside standard immunotherapy (pembrolizumab) and chemotherapy can improve outcomes in people with metastatic lung adenocarcinoma. It’s meant for people who have measurable tumors that can be safely targeted with the freezing treatment.
Bordeaux, GirondeAges 18 years+ - NCT04258319Enrolling by invitation
Limb fluid swelling study using arm and leg motion tests
This study looks at how swollen fluid (lymphedema) behaves in the arms and legs using measurements taken from your movement. It aims to better understand the changes in limb tissue, which could help guide future care.
Jacksonville, FloridaAges 18 years+ - NCT04299945Recruiting
Beetroot juice to boost exercise in fibrotic lung disease
This trial tests whether drinking beetroot juice can improve exercise performance in people with fibrotic interstitial lung disease (scarring in the lungs). It may help your body use oxygen better during activity if you meet the study’s safety and lung-function requirements.
Vancouver, British ColumbiaAges 19 years+ - NCT04309487Recruiting
Check shunt blockage using ShuntCheck versus a scan
This study tests whether a device called ShuntCheck can accurately tell if a VP (ventriculoperitoneal) shunt is blocked in people with normal pressure hydrocephalus. If it works well, it may help doctors find shunt problems faster and more safely.
Tampa, FloridaAges 40 years+ - NCT04307277RecruitingPhase 3
Chemotherapy before and after surgery for high-risk soft tissue sarcoma
This trial tests whether giving chemotherapy both before and after surgery helps people with high-risk soft tissue sarcoma live longer and prevents the cancer from coming back. It aims to see if this treatment plan is more effective than surgery alone.
BesançonAges 18 years+ - NCT04298723Recruiting
Left atrial appendage closure vs blood thinners after brain bleed
This trial compares a procedure that blocks a heart blood-choke point (the left atrial appendage) versus taking blood thinners by mouth. It is for people with atrial fibrillation who have had a brain bleed and may be safer avoiding long-term blood thinners.
Mannheim, Baden-WurttembergAges 18 years+ - NCT03144167Recruiting
Blood and scan markers to predict benefit from bevacizumab
This study looks for blood test markers that may predict who survives at 6 months after starting bevacizumab for glioblastoma that has come back. It does not aim to cure the cancer by itself, but to improve doctors’ ability to choose the most helpful treatment plan.
Amiens, PicardieAges 18 years+ - NCT03042988Recruiting
Heat stress test in people with low nerve control and high blood pressure
This study checks how your body’s blood pressure and stress responses change after being exposed to heat overnight. It’s meant for people with autonomic failure (like certain Parkinson-related or nerve-function conditions) who also have high blood pressure while lying down, which may help researchers understand safer ways to manage it.
Nashville, TennesseeAges 18–80 - NCT04024917Recruiting
Cardiac coherence training to reduce anxiety before abdominal surgery
This trial tests whether “cardiac coherence” breathing/relaxation practice can lower anxiety in people with peritoneal cancer who are scheduled for a major surgery. It may help by calming stress before and around the operation.
Montpellier, HéraultAges 18 years+ - NCT04181060RecruitingPhase 3
Osimertinib alone or with bevacizumab for EGFR-mutant lung cancer
This Phase 3 trial tests whether starting osimertinib with or without bevacizumab helps people with advanced EGFR-mutant lung cancer live longer and control the cancer better. Your EGFR mutation test result and past treatments are key to whether you can join.
Anchorage, AlaskaAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,161 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.